D-1169-2017 Class II Terminated

Recalled by Noven Pharmaceuticals, Inc. — Miami, FL

FDA drug recall D-1169-2017 was initiated by Noven Pharmaceuticals, Inc. on Aug 30, 2017 and is designated Class II. Reason for recall: Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic. The recall status is terminated (terminated Jan 24, 2020). Affected quantity: 321,900 patches.

Recall details

Product Type
Drugs
Report Date
Sep 27, 2017
Initiation Date
Aug 30, 2017
Termination Date
Jan 24, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
321,900 patches

Product description

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5552-3

Reason for recall

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Distribution pattern

Nationwide.

Code information

Lot: 80433 Exp. 08/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1169-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1169-2017. Report a data issue: hello@regdatalab.com.